XML 92 R76.htm IDEA: XBRL DOCUMENT v3.25.1
Note 16 - Restatement (Unaudited) - Schedule of Restated Cash Flow Statements (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Dec. 31, 2024
Sep. 30, 2024
Jun. 30, 2024
Jun. 30, 2024
Sep. 30, 2024
Dec. 31, 2024
Dec. 31, 2023
Net income (loss)       $ 3,737 $ 3,468 $ (2,687) $ 4,776
Depreciation and amortization       989 1,443 1,616 2,001
Amortization of operating lease right-of-use assets       310 415 545 875
Provision for expected credit losses       89 133 128 88
Deferred income tax expense       1,349 4,577 (1,500) 921
(Gain) / loss on sale of business       (4,558) (3,598) (1,348) 408
Share based compensation       256 107 137 297
Accounts receivable, net       (9,766) (5,843) (5,656) 3,232
Prepaid expenses and other current assets       (2,620) (2,383) (2,375) 2,082
Change in deferred taxes due to deconsolidation       2,307      
Accounts payable       1,992 3,832 6,958 (2,960)
Operating lease liabilities       (310) (415) (541) (875)
Accrued expenses, other current liabilities, due to affiliates and customer incentives and deposits       6,395 (2,466) 4,058 (4,024)
Net cash (used in) provided by operating activities       170 (730) (665) 6,821
Proceeds from sale of joint ventures, net of cash transferred       11,743 10,436    
Purchases of property and equipment       (781) (908) (1,139) (1,242)
Net cash provided by (used in) investing activities       10,962 9,528 9,881 (2,269)
Borrowings under line of credit       69,117 103,184 132,133 103,742
Repayments under line of credit       (64,044) (97,782) (128,347) (104,845)
Proceeds from term debt       26 16    
Repurchases of common stock       (1,800) (1,800) (1,800) 0
Payments of notes to seller       (1,843) (1,843) (1,843) 0
Payments to acquire noncontrolling interests       (250) (250) (500) (473)
Dividend on noncontrolling interest       (1,315) (1,315) (1,315) (1,673)
Net cash (used in) financing activities       (109) 210 (1,657) (3,020)
Effect of foreign exchange rate changes on cash       (48) (75) (58) (158)
Net increase in cash and cash equivalents       10,976 8,933 7,502 1,374
Cash and cash equivalents at beginning of year $ 19,652 $ 21,695   10,719 10,719 10,719 9,345
Cash and cash equivalents at end of year 18,221 19,652 $ 21,695 21,695 19,652 18,221 10,719
Interest paid       1,030 1,640 2,059 2,331
Income taxes paid       277 277 277 1,585
Previously Reported [Member]              
Net income (loss)   (232) 4,075 11,255 11,024    
Depreciation and amortization       989 1,443    
Amortization of operating lease right-of-use assets       310 415    
Provision for expected credit losses       89 133    
Deferred income tax expense       1,349 4,577    
(Gain) / loss on sale of business   922 (4,919) (12,076) (11,154)    
Share based compensation       256 107    
Accounts receivable, net       (9,766) (5,843)    
Prepaid expenses and other current assets       (2,620) (2,383)    
Change in deferred taxes due to deconsolidation       2,307      
Accounts payable       1,992 3,832    
Operating lease liabilities       (310) (415)    
Accrued expenses, other current liabilities, due to affiliates and customer incentives and deposits       6,395 (2,466)    
Net cash (used in) provided by operating activities       170 (730)    
Proceeds from sale of joint ventures, net of cash transferred       11,743 10,436    
Purchases of property and equipment       (781) (908)    
Net cash provided by (used in) investing activities       10,962 9,528    
Borrowings under line of credit       69,117 103,184    
Repayments under line of credit       (64,044) (97,782)    
Proceeds from term debt       26 16    
Repurchases of common stock       (1,800) (1,800)    
Payments of notes to seller       (1,843) (1,843)    
Payments to acquire noncontrolling interests       (250) (250)    
Dividend on noncontrolling interest       (1,315) (1,315)    
Net cash (used in) financing activities       (109) 210    
Effect of foreign exchange rate changes on cash       (48) (75)    
Net increase in cash and cash equivalents       10,976 8,933    
Cash and cash equivalents at beginning of year 19,652 21,695   10,719 10,719 10,719  
Cash and cash equivalents at end of year   19,652 21,695 21,695 19,652   10,719
Interest paid       1,030 1,640    
Income taxes paid       277 277    
Revision of Prior Period, Adjustment [Member]              
Net income (loss)   (38) (7,518) (7,518) (7,556)    
Depreciation and amortization       0 0    
Amortization of operating lease right-of-use assets       0 0    
Provision for expected credit losses       0 0    
Deferred income tax expense       0 0    
(Gain) / loss on sale of business   38 7,518 7,518 7,556    
Share based compensation       0 0    
Accounts receivable, net       0 0    
Prepaid expenses and other current assets       0 0    
Change in deferred taxes due to deconsolidation       0      
Accounts payable       0 0    
Operating lease liabilities       0 0    
Accrued expenses, other current liabilities, due to affiliates and customer incentives and deposits       0 0    
Net cash (used in) provided by operating activities       0 0    
Proceeds from sale of joint ventures, net of cash transferred       0 0    
Purchases of property and equipment       0 0    
Net cash provided by (used in) investing activities       0 0    
Borrowings under line of credit       0 0    
Repayments under line of credit       0 0    
Proceeds from term debt       0 0    
Repurchases of common stock       0 0    
Payments of notes to seller       0 0    
Payments to acquire noncontrolling interests       0 0    
Dividend on noncontrolling interest       0 0    
Net cash (used in) financing activities       0 0    
Effect of foreign exchange rate changes on cash       0 0    
Net increase in cash and cash equivalents       0 0    
Cash and cash equivalents at beginning of year $ 0 0   0 0 $ 0  
Cash and cash equivalents at end of year   $ 0 $ 0 0 0   $ 0
Interest paid       0 0    
Income taxes paid       $ 0 $ 0